Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Crit Care Med. 2019 Jul;47(7):951–959. doi: 10.1097/CCM.0000000000003779

Table #1.

Characteristics of the patients at baseline

Characteristic Restrictive fluid group
(n=55)
Usual care group
(n=54)
Age – yr, median (IQR) 71 (60–82) 73.5 (54–81)
Male sex – n (%) 24 (43.6) 26 (48.2)
Weight – kg, median (IQR) 84.3 (75.4–103.5) 78.3 (69.9–92.3)
BMI – kg/m2, median (IQR) 30.7 (26.8–35.6) 28.7 (24.3–33.0)
Long term care facility resident – n (%) 10 (18.2) 9 (16.7))
Physiologic variables
 APACHE II score – meana 35.4 ±6.9 35.7 ±7.4
 SOFA score – median (IQR) 8 (7–11) 8.5 (7–12)
 Mean arterial pressure – mmHg, median (IQR) 51.7 (46.7–55.7) 53.5 (46.3–58.7)
 Serum lactate – mmol/liter, median (IQR) 2.0 (1.4–3.7) 3.0 (1.5–5.3)
Entry criteria – n (%)
 Refractory hypotension 52 (93.4) 47 (87.0)
 Lactic >4mmol/Lb 2 (3.6) 7 (13.0)
Time from triage to randomization – hours, median (IQR) 8.8 (4.3–20.8) 9.1 (5.5–14.5)
Chronic medical condition – n (%)
 Diabetes mellitus 23 (41.8) 18 (33.3)
 Chronic kidney diseasec 20 (36.4) 6 (11.1)
 Baseline dialysis 7 (12.7) 1 (1.9)
 Congestive heart failure 18 (32.7) 13 (24.1)
 Chronic respiratory failure 12 (21.8) 15 (27.8)
 Baseline mechanical ventilation 2 (3.6) 2 (3.7)
 Immune modifying medication 11 (20.0) 7 (13.0)
 Chronic liver disease 5 (9.1) 8 (14.8)
 Lymphoma, leukemia, multiple myeloma 5 (9.1) 4 (7.4)
 Metastatic Cancer 2 (3.6) 5 (9.3)
 Organ transplant 4 (7.3) 0 (0)
Site of infection – n (%)
 Pulmonary 13 (23.6) 17 (31.5)
 Urinary tract 15 (27.3) 14 (25.9)
 Abdominal 7 (12.7) 4 (7.4)
 Skin/soft tissue 8 (14.6) 2 (3.7)
 Endocarditis 2 (3.6) 1 (1.9)
 Indwelling catheter or device 1 (1.8) 1 (1.9)
 Multiple sites 6 (10.9) 7 (13.0)
 Unknown 3 (5.5) 8 (14.8)
a

± indicates standard deviation

b

One patient has missing data

c

Patient baseline characteristics are equally balanced except for chronic kidney disease

IQR= interquartile range